<DOC>
	<DOCNO>NCT00712400</DOCNO>
	<brief_summary>Latanoprost synthetic prodrug 17-phenyl-substituted prostaglandin F2Î± analog . Used dose one drop per day , report produce 30 35 % reduction intraocular pressure . Its mechanism activation involve augmentation eye 's natural uveoscleral outflow capacity . There evidence ocular blood flow play role clinical course glaucoma . Glaucoma medication lower IOP simultaneously increase ocular blood perfusion pressure , turn may increase ocular blood flow . This could well contribute partially contradict result concern ocular hemodynamic effect latanoprost . In vitro study indicate latanoprost effect ocular vascular tone therapeutical dos . By contrast , report several study latanoprost 0.005 % increase pulsatile ocular blood flow patient primary open angle glaucoma normal tension glaucoma . This increase pulsatile ocular blood flow mainly reflect increase choroidal circulation . Little known potential effect latanoprost choroidal blood flow regulation human . The present study therefore try elucidate whether treatment latanoprost may alter choroidal blood flow regulation artificial change ocular perfusion pressure . In addition , present study aim clarify whether change choroidal blood flow latanoprost administration due direct vasoactive effect due increase ocular perfusion pressure . The second alternative may important implication understand glaucoma treatment , reduction IOP may per se result normalization ocular blood flow regulation .</brief_summary>
	<brief_title>Effects Latanoprost Choroidal Blood Flow Regulation Human Subjects</brief_title>
	<detailed_description />
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Men age 19 35 year , nonsmoker Body mass index 15th 85th percentile ( Must et al . 1991 ) Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant Normal ophthalmic finding , ametropia &lt; 3 dpt . Regular use medication , abuse alcoholic beverage , participation clinical trial 3 week precede study Treatment previous 3 week drug Symptoms clinically relevant illness 3 week first study day History presence gastrointestinal , liver kidney disease , condition know interfere distribution , metabolism excretion study drug Blood donation previous 3 week Ametropia &gt; = 3 dpt Iris bicolor</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Latanoprost</keyword>
	<keyword>Choroidal Blood Flow</keyword>
	<keyword>Intraocular Pressure</keyword>
</DOC>